Matulionė, J. 2022. FIRST-LINE NIVOLUMAB PLUS IPILIMUMAB COMBINED WITH TWO CYCLES OF CHEMOTHERAPY IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER. Pulmonology and allergology. 6, 1 (Jun. 2022), 97-104. DOI:https://doi.org/10.37499/PIA.973.